Azerbaijani
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Pharmacokinetics of Benzo[a]Pyrene: Impact of Diet

Yalnız qeydiyyatdan keçmiş istifadəçilər məqalələri tərcümə edə bilərlər
Giriş / Qeydiyyatdan keçin
Bağlantı panoya saxlanılır
StatusAktiv, işə qəbul deyil
Sponsorlar
Oregon State University
Əməkdaşlar
National Institute of Environmental Health Sciences (NIEHS)
Lawrence Livermore National Laboratory
Pacific Northwest National Laboratory

Açar sözlər

Mücərrəd

Evaluation of the pharmacokinetics for [14C]-benzo[a]pyrene ([14C]-BaP) and metabolites in plasma and urine over 48 hours following a 50 ng dose (5.4 nCi) alone, following 7 days' consumption of Brussels sprouts, and following 7 days' consumption of a supplement containing 3,3'-diindolylmethane (DIM).

Təsvir

The pharmacokinetics for [14C]-BaP and metabolites will be assessed by UHLPC-Accelerator Mass Spectrometry (AMS, Lawrence Livermore National Laboratory) in plasma and urine collected over 48 hours following oral doses of 50 ng dose (5.4 nCi) alone, following 7 days' consumption of Brussels sprouts, and following 7 days' consumption of a supplement containing 3,3'-diindolylmethane (DIM).

The investigators hypothesize that pre-administration of Brussels sprouts or DIM will alter [14C]-BaP metabolism and increase the rate of elimination consistent with predictions based on a previously developed Physiologically-Based Pharmacokinetic (PBPK) model for BaP. Briefly, this hypothesis will be tested by dosing individuals with 50 ng [14C]-BaP alone and, following a 3-week washout period, ingestion of about 50 g Brussels sprouts or 300 mg of 3,3'-diindolylmethane (DIM) supplement for 7 days prior to the [14C]-BaP micro-dose. The impact of the supplement and the whole food will be assessed with respect to alterations in uptake from the GI tract, metabolism and rate of elimination. The consumption of cruciferous vegetables will be assessed at the beginning of the study by completion of a dietary questionnaire to examine typical eating patterns in the previous 3 months and by collection and extraction of blood and urine to assay for DIM by LC/ESI-MS/MS-SRM). In addition, for each phase, urine will be assayed for DIM as an estimate of crucifer or DIM supplement intake.

In preclinical and clinical studies, administration of Brussels sprouts or DIM impacts the activity of the same enzymes responsible for the phase 1 (CYP1A1 and CYP1B1) and phase 2 enzymes (GSTM1, UGT, SULT). Monitoring changes in β-estradiol metabolites will confirm the mechanism of alteration in the metabolic profile of [14C]-BaP.

Metabolite profiles and kinetics of elimination are predicted to be consistent with a BaP physiologically based pharmacokinetic (PBPK) model developed by Pacific Northwest National Laboratory (PNNL). A non-smoker, not exposed occupationally, receives 270-700 ng of BaP daily; about 95% dietary. The WHO has set an estimated safe daily lifetime (70 year/70 Kg individual, cancer endpoint) exposure to BaP of 42-350 ng. This protocol represents de minimus risk.

Tarixlər

Son Doğrulandı: 02/29/2020
İlk təqdim: 01/09/2019
Təxmini qeydiyyat təqdim edildi: 01/09/2019
İlk Göndərmə: 01/13/2019
Son Yeniləmə Göndərildi: 03/29/2020
Son Yeniləmə Göndərildi: 03/31/2020
Həqiqi Təhsilin Başlama Tarixi: 12/31/2018
Təxmini İlkin Tamamlanma Tarixi: 12/30/2020
Təxmini İşin Tamamlanma Tarixi: 12/30/2022

Vəziyyət və ya xəstəlik

Environmental Exposure

Müdaxilə / müalicə

Drug: 50 ng dose

Drug: Brussels sprouts before 50 ng dose

Drug: DIM supplement before 50 ng dose

Faza

-

Qol Qrupları

QolMüdaxilə / müalicə
Experimental: 50 ng dose
Capsule containing 50 ng (5.4 nCi) [14C]-benzo[a]pyrene (BaP)
Drug: 50 ng dose
Oral micro-dose (50 ng) (5.4 nCi)
Experimental: Brussels sprouts before 50 ng dose
Subjects will consume 50 g (about 1/2 cup) of lightly steamed Brussels sprouts each evening for 7 days prior to taking capsule containing 50 ng (5.4 nCi) [14C]-benzo[a]pyrene (BaP)
Drug: Brussels sprouts before 50 ng dose
Brussels sprouts for 7 days before 50 ng (5.4 nCi) dose of BaP
Experimental: DIM supplement before 50 ng dose
Subjects will consume 300 mg DIM supplement ( 2 capsules of BioResponse DIM® 150) each evening for 7 days prior to taking capsule containing 50 ng (5.4 nCi) [14C]-benzo[a]pyrene (BaP). A 300 mg DIM dose will be co-administrated with the 50 ng BaP dose
Drug: DIM supplement before 50 ng dose
DIM supplement for 7 days before 50 ng (5.4 nCi) dose of BaP and coadministration with DIM supplement

Uyğunluq Kriteriyaları

Təhsil üçün uyğun yaşlar 21 Years Üçün 21 Years
Təhsilə Uyğun CinslərAll
Sağlam Könüllüləri qəbul edirBəli
Kriteriyalar

Inclusion Criteria:

- Age 21-65 (inclusive)

- If female, must be post-menopausal or have had surgical sterilization to eliminate any possibility for fetal exposure

- Willing to defer blood donation for one month before, throughout, and one month after completion of study activities

- Willing to avoid consuming cruciferous vegetables, I3C or DIM supplements, smoked or cured meat or cheeses, or charcoal-grilled meats for 2 weeks prior to and during each study cycle (gas grilled foods acceptable)

- Health history review and physical assessment showing general good health, as determined by study physician. Acceptable physical exam may have been conducted as part of protocol 8233 or 8554 if subject has not had significant changes in health status.

Exclusion Criteria:

- Smoker (tobacco or other substances) or use of smokeless tobacco in past 3 months or living with smoker

- Regular use of medications that affect gut motility or nutrient absorption (e.g. cholestyramine, sucralfate, orlistat, pro- or anti-motility agents)

- History of gastrointestinal surgery (e.g. bariatric surgery, cholecystectomy) or gastrointestinal disorder (Crohn's disease, celiac disease, IBS, or colitis)

- Current or history of kidney or liver disease

- Prior high-dose 14C exposure from medical tests. (micro-dose 14C exposure not exclusionary)

- Occupational PAH exposure (e.g. roofers, asphalt pavers, fire-fighters, etc.)

- Regular use of indole-3-carbinol or DIM dietary supplements

- Allergy or intolerance to Brussels sprouts or similar foods

Nəticə

İlkin nəticə tədbirləri

1. Plasma and urine 14C-BaP and 14C-BaP metabolite levels after oral dose [48 hours]

Plasma and urine levels of 14C-BaP and 14C-BaP metabolites measured by accelerator mass spectrometry

İkincili Nəticə Tədbirləri

1. Peak plasma concentration of 14C-BaP Cmax [48 hours]

Determination of highest concentration of 14C-BaP in plasma

2. Time at highest plasma concentration of 14C-BaP Tmax [48 hours]

Determination of time at which plasma concentration of 14C-BaP is highest

3. Area under plasma concentration of 14C-BaP versus time curve AUC [48 hours]

Integration of concentration of 14C-BaP in plasma over time

4. Rate of elimination of 14C-BaP [48 hours]

Determination of constants for rate of elimination of 14C-BaP from plasma

5. Metabolites of 14C-BaP in plasma [48 hours]

Determination of plasma metabolites of 14C-BaP

6. Metabolites of 14C-BaP in urine [48 hours]

Determination of urinary metabolites of 14C-BaP

7. Metabolites of B-estradiol in urine [-7 days and 48 hours]

Determination of urinary metabolites of B-estradiol

8. Metabolites of B-estradiol in plasma [-7 days and 48 hours]

Determination of plasma metabolites of B-estradiol

9. Metabolites of DIM in plasma [-7 days and 48 hours]

Determination of plasma metabolites of DIM

10. Metabolites of DIM in urine [-7 days and 48 hours]

Determination of urinary metabolites of DIM

Facebook səhifəmizə qoşulun

Elm tərəfindən dəstəklənən ən tam dərman bitkiləri bazası

  • 55 dildə işləyir
  • Elm tərəfindən dəstəklənən bitki mənşəli müalicələr
  • Təsvirə görə otların tanınması
  • İnteraktiv GPS xəritəsi - yerdəki otları etiketləyin (tezliklə)
  • Axtarışınızla əlaqəli elmi nəşrləri oxuyun
  • Təsirlərinə görə dərman bitkilərini axtarın
  • Maraqlarınızı təşkil edin və xəbər araşdırmaları, klinik sınaqlar və patentlər barədə məlumatlı olun

Bir simptom və ya bir xəstəlik yazın və kömək edə biləcək otlar haqqında oxuyun, bir ot yazın və istifadə olunan xəstəliklərə və simptomlara baxın.
* Bütün məlumatlar dərc olunmuş elmi araşdırmalara əsaslanır

Google Play badgeApp Store badge